CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 5, 2022 · earnings

NTLA earnings: a negative outcome, -10.2%

On May 5, 2022, Intellia Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -10.2% in the window around the event. It had already run -26.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$55.70
1d before
$50.03
Event day
$47.57
1d after
$44.40
5d after

Pre-catalyst setup

-26.4%
30-day run-up
6539%
30-day volatility
1.7×
volume spike